Dr. Clancy is an infectious diseases physician and researcher, and tenured faculty member at the University of Pittsburgh. His research laboratory studies the molecular pathogenesis of invasive infections caused by the fungus Candida albicans and bacterium Klebsiella pneumoniae, and the mechanisms of antimicrobial resistance utilized by both organisms. His team have implicated several novel genes in both organisms in the pathogenesis of infections, and in tolerance and resistance to antimicrobial treatment. His clinical research focuses on fungal and antimicrobial resistant bacterial infections, particularly in transplant recipients, novel diagnostic tests for infectious diseases and antimicrobial resistance, and antimicrobial drug development in the US. His research is funded by the National Institutes of Health (NIH), US Department of Veterans Affairs, and other sources. He has authored >180 research papers and numerous book chapters on infectious diseases and antimicrobials. He is editor of the American Society for Microbiology's Candida and Candidiasis textbook, and he is a member of antimicrobial resistance committees for the Infectious Diseases Society of America and NIH-supported Antimicrobial Resistance Leadership Group. Dr. Clancy has received medical teaching awards from the Universities of Florida and Pittsburgh. He is recognized as a Best Doctor in Pittsburgh.